Bio-Connect
IHC-P analysis of human bladder carcinoma tissue using GTX34814 MAML2 antibody [MAML2/1302].
IHC-P analysis of human bladder carcinoma tissue using GTX34814 MAML2 antibody [MAML2/1302].
IHC-P analysis of human bladder carcinoma tissue using GTX34814 MAML2 antibody [MAML2/1302].

MAML2 antibody [MAML2/1302]

GTX34814
GeneTex
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetMAML2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    MAML2 antibody [MAML2/1302]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1-2microg/ml. ICC/IF: 1-2microg/ml. IHC-P: 1-2microg/ml for 30 minutes at RT. FACS: 1-2microg/106 cells. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MAML2/1302
  • Concentration
    0.2 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID84441
  • Target name
    MAML2
  • Target description
    mastermind like transcriptional coactivator 2
  • Target synonyms
    MAM2; mam-2; MAM3; MAM-3; mastermind-like 2; mastermind-like protein 2; MLL-MAML2
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDQ8IZL2
  • Protein Name
    Mastermind-like protein 2
  • Scientific Description
    The protein encoded by this gene is a member of the Mastermind-like family of proteins. All family members are proline and glutamine-rich, and contain a conserved basic domain that binds the ankyrin repeat domain of the intracellular domain of the Notch receptors (ICN1-4) in their N-terminus, and a transcriptional activation domain in their C-terminus. This protein binds to an extended groove that is formed by the interaction of CBF1, Suppressor of Hairless, LAG-1 (CSL) with ICN, and positively regulates Notch signaling. High levels of expression of this gene have been observed in several B cell-derived lymphomas. Translocations resulting in fusion proteins with both CRTC1 and CRTC3 have been implicated in the development of mucoepidermoid carcinomas, while a translocation event with CXCR4 has been linked with chronic lymphocytic leukemia (CLL). Copy number variation in the polyglutamine tract has been observed. [provided by RefSeq, Jan 2015]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203